Image CreditFDRLST/Canva
The Supreme Court ruled last week that the Alliance for Hippocratic Medicine et al., a coalition of medical professionals sworn to “protecting the vulnerable at the beginning and end of life,” did not have adequate legal standing to challenge the U.S. Food and Drug Administration’s rushed approval and mail-order expansion of the drug regimen responsible for more than half of the nation’s abortions.
Corporate media gladly used the unanimous decision, which was largely procedural and did not offer a moral or legal judgment on the actual use of abortion pills, as ammo to fuel their abortion allies’ attempts to expand baby-killing even in the dozens of pro-life states that have restricted or banned it.
Only a few were willing to admit that the true nature of the opinion penned by Justice Brett Kavanaugh leaves the door wide open for a stronger challenge to make its way to the high court. Kansas, Idaho, and Missouri, whose attempts to join the SCOTUS case were declined, already appear teed up for more viable legal action over the abortion pill.
SCOTUS’s refusal to rule on the merits of the Alliance for Hippocratic Medicine’s case, however, also leaves the door open for abortion activists and their elected allies to do everything in their power to solidify mifepristone’s presence in their post-Dobbs v. Jackson baby-killing schemes. Especially because the court’s instruction for those worried about the pill to take it up with the administrative state will likely fall on the FDA’s
